含可脱除侧基的功能化微凝胶及其在药物释放中的应用

环境敏感微凝胶由于其对外界刺激的快速响应能力在药物传输和释放领域得到广泛的关注.本文报道了一种侧链含可脱除基团的温敏微凝胶,并探讨了其在药物释放中的潜在应用.通过分子设计,合成出含侧链N-叔丁氧羰基(N-Boc)的疏水单体N-(N-叔丁氧羰基-乙二胺)甘氨酸二肽甲基丙烯酰胺(BEMAGG),然后将其与N-异丙基丙烯酰胺(NIPAAm)沉淀共聚合直接得到侧链含Boc基团的微凝胶MG-Boc.通过浊点法、粒径和Zeta电位测定研究了微凝胶中Boc基团在酸中的脱除过程及其对微凝胶性能的影响,研究表明Boc基团的脱除显著影响微凝胶的体积相转变温度、粒径和Zeta电位.对盐酸阿霉素药物的释放研究表明,释放明显依赖于释放介质的pH值.该响应性的微凝胶在药物控制释放领域具有潜在的应用前景.     

聚(醚-酐)凝胶性能的优化及用于包载难溶性药物的研究

在制备聚醚酐凝胶的基础上, 用两种不同的可光交联疏水性单体与聚醚酐大分子单体在紫外光引发下制备三维交联凝胶, 使得凝胶的溶胀性能和亲-疏水性能发生变化, 从而影响凝胶与难溶性药物的相容性; 选用吲哚美辛为模型药物, 通过后包合法将其包载于凝胶网络中, X射线衍射(XRD)检测结果表明, 药物能以分子或无定形态分散于其中, 优化后的凝胶可得到更高的载药量和包封率, 能有效地提高疏水性药物的溶出度, 且药物体外释放速率与单纯聚醚酐凝胶相比, 被有效延缓, 更适于临床应用.     

海藻酸钠的疏水改性及释药性能研究

为了提高对疏水性药物的负载量和缓释作用,将海藻酸钠氧化后与十二胺反应使其进行疏水改性.对改性后聚合物结构进行了表征.研究了聚合物在水溶液及盐溶液中的粘度变化;将聚合物分散于NaCl/CaCl2的混合溶液中制备成凝胶微球,对药物布洛芬进行了包埋释放实验.结果表明,疏水改性后的海藻酸钠粘度增加,其凝胶微球对布洛芬负载量提高,具有较好的缓释作用.     

温敏性PCL-PEG-PCL水凝胶的合成、表征及蛋白药物释放

考察了温敏性PCL-PEG-PCL水凝胶中聚乙二醇(PEG)及聚己内酯(PCL)不同嵌段组成对其溶胶-凝胶相转变温度以及亲水性药物(牛血清白蛋白, BSA)释放速率的影响. 采用开环聚合法, 以辛酸亚锡为催化剂、PEG1500/PEG1000为引发剂, 与己内酯单体发生开环共聚, 合成了一系列具有不同PEG和PCL嵌段长度的PCL-PEG-PCL型三嵌段共聚物. 通过核磁共振氢谱及凝胶渗透色谱对其组成、结构及分子量进行了表征. 共聚物的溶胶-凝胶相变温度由翻转试管法测定. 利用透射电镜、核磁共振氢谱及荧光探针技术证实了该材料在水溶液中胶束的形成. 以BSA为模型蛋白药物, 制备载药水凝胶, 利用microBCA法测定药物在释放介质中的浓度, 研究其体外释放行为. 实验结果表明, 共聚物的溶胶-凝胶相变温度与PCL及PEG嵌段长度紧密相关, 即在给定共聚物浓度情况下, 固定PEG嵌段长度而增加PCL嵌段长度, 会导致相变温度降低; 而固定PCL嵌段长度而增加PEG嵌段长度, 其相变温度相应升高. 水凝胶中蛋白药物的释放速率与疏水的PCL嵌段长度无关, 而与亲水的PEG嵌段长度密切相关, 即PEG嵌段越长, 蛋白药物释放越快.     

溶剂和分子结构对席夫碱分子在有机凝胶中的荧光增强和超分子手性的影响

研究了在有机胶凝剂中掺杂的席夫碱化合物的结构和性质. 实验发现, 虽然席夫碱分子单独不能在有机溶剂中形成凝胶, 当其与一种胶凝剂N,N’-双十八烷基-L-Boc-谷氨酸混合时, 它们在二甲基亚砜或甲苯中形成透明的有机凝胶. 与相应的溶液相比, 观察到在有机凝胶中的荧光增强现象, 并且这一增强与席夫碱的结构有密切关系. 在二甲基亚砜的有机凝胶中, 观察到带有长烷基链的席夫碱具有诱导手性. 表明通过凝胶的形成, 胶凝剂的手性能传递到带有长链的席夫碱上.     

疏水改性凝胶的合成及其药物释放性能的研究

以偶氮二异丁腈为引发剂,通过化学引发聚合合成甲基丙烯酸β-羟乙酯(HEMA)/N-乙烯基吡咯烷酮(NVP)二元共聚物和HEMA/NVP/甲基丙烯酸乙酯(或甲基丙烯酸丁酯)三元共聚物水凝胶,研究了凝胶在不同的酸度介质中对小分子药物阿司匹林的释放过程,结果表明,在模拟胃肠道条件下,随着疏水性单体的加入使凝胶的药物释放速率减缓,可实现药物的控制缓释作用。     

含顺反异构双胆固醇型小分子胶凝剂的合成与胶凝行为

以甘氨酸为连接臂,以顺反丁烯二酸为功能基团设计合成了两种具有不同立体异构连接臂的A(LS)2型双胆固醇类小分子胶凝剂MA-C和FA-C. 考察了MA-C和FA-C对30种常见有机溶剂中的胶凝能力. 结果表明：MA-C和FA-C的胶凝能力及其所形成凝胶的性质依赖于胶凝剂分子的立体异构. 值得一提的是,MA-C能使CCl4室温胶凝,而且所形成凝胶具有良好的热稳定性和显著的剪切触变性. 更为有趣的是,此胶凝剂还能在水/CCl4混合体系中选择胶凝有机相. 显微分析表明,凝胶中胶凝剂的聚集体形貌不仅依赖于胶凝剂分子的立体异构,胶凝剂的浓度,而且也和胶凝剂分子与溶剂分子间的相互作用有关. 变温、变浓度1H NMR研究表明胶凝剂分子间的π-π堆积和氢键作用是凝胶形成的重要驱动力. 此外,根据XRD和其它实验结果提出了MA-C在CCl4中的可能堆积模型.     

PEGDA/NIPAM共聚物水凝胶的药物释放性能研究

以IRGACURE2959为光引发剂,聚乙二醇双丙烯酸酯(PEGAD)和N-异丙基丙烯酰胺(NIPAM)为单体,通过紫外光引发光聚合,合成了PEGDA/NIPAM共聚物水凝胶,研究了凝胶于不同酸度介质及不同温度中对阿司匹林的释放行为。结果表明,模拟胃肠液中,随释放时间的延长,载药凝胶对药物的累积释放率增加。NIPAM单体的引入增大药物累积释放率,药物缓释时间延长,具有良好的药物释放性能。凝胶对药物的缓释受温度与释放时间的影响,在37℃和45℃时,随释放时间增加,药物累积释放率增大;在30℃时,随释放时间的增长,累积释放率先增大后减小。     

偶氮聚合物作为结肠靶向药物载体的研究进展

在人体消化道中,偶氮键仅能被结肠厌氧菌代谢的偶氮还原酶还原在耐断裂,偶氮聚合物可作为潜在的高定位性的结肠靶向药物缓释载体,根据合成方法和最终的释药方式,偶氮聚合物药物释放体系可分为水凝胶体系,胞衣体系和聚合物前药体系。     

温敏性PNIPAAm水凝胶对布洛芬的控制释放

采用自由基聚合法在水溶液中制备了温敏水凝胶聚N-异丙基丙烯酰胺(PNIPAAm),以非水溶性药物布洛芬(IBU)为模型药物分子,研究了该水凝胶的温敏性能及与药物IBU的相互作用,考察了不同温度下(25 ℃和37 ℃)IBU在磷酸盐缓冲溶液(PBS,pH=7.4)中的释放行为.研究结果表明:该水凝胶的最低临界溶解温度(L...     

Preparation of thermosensitive polymeric organogels and their drug release behaviors

Stimuli-sensitive drug delivery systems—in particular, stimuli-sensitive polymeric hydrogels swollen with water—have attracted considerable attention in medical and pharmaceutical fields. This study concerns with the synthesis of thermosensitive polymeric organogels for controlled drug release; a copolymerization of stearyl acrylate (SA) with a cross-linker and the loading of indomethacin as a model lipophilic drug were accomplished in oleyl alcohol. The pulsatile (on-off) drug release was successfully conducted: release was halted at 36 °C and release occurred at over ca. 40 °C. This drug release pattern is suitable for thermochemotherapy combined with hyperthermia. The differential scanning calorimetric measurement suggests the following mechanism: the ordered crystalline structure, i.e., the alignment of hydrophobic alkyl side chains, works to prevent indomethacin diffusion from the organogel below the crystallization temperature, while the disordered amorphous structure above the melting temperature allows indomethacin to diffuse.     

Controlled release of dual drugs from emulsion electrospun nanofibrous mats

The purpose of this work is to develop a novel type of tissue engineering scaffold or drugs delivery carrier with the capability of encapsulation and controlled release drugs. In this study, Rhodamine B and Bovine Serum Albumin (BSA) were successfully incorporated into nanofibers by means of emulsion electrospinning. The morphology of composite nanofibers was studied by Scanning Electron Microscopy (SEM). The composite nanofibrous mats made from emulsion electrospinning were characterized by water contact angle measurement and X-ray diffraction. In vitro dual drugs release behaviors from composite nanofibrous mats were investigated. The results indicated that the incorporated drug and/or proteins in composite fibrous mats made from electrospinning could be control released by adjusting the processes of emulsions preparation.     

聚甘油酸-g-胆固醇胶束的制备及药物释放性能研究

以甘油酸为单体,通过本体缩聚制备了水溶性生物降解高分子聚甘油酸,利用聚甘油酸侧基上的羟基固定生物相容性好的疏水性分子胆固醇,通过亲疏水作用自组装形成胶束.以形成的胶束作为载体负载抗肿瘤药物阿霉素,研究了药物的体外释放行为.将肝癌细胞HepG2与载药胶束共培养研究其体外抗肿瘤效果.研究结果表明,聚甘油酸-g-胆固醇共聚物...     

Fusiform micelles from nonlinear poly(ethylene glycol)/polylactide copolymers as biodegradable drug carriers

PEG-PLA copolymers with dumbbell- and Y-shaped structures are prepared. They can self-assemble from nanoparticles to micro-sized fusiform micellar particles in aqueous solution. In particular the micelles formed by the (PLA)2-PEG-(PLA)2 particles show a better drug loading capacity and encapsulation efficiency than those formed by linear MPEG-PLA. In vitro studies show that the particles formed by Y-shaped copolymers show a particularly quick drug release. The copolymers have good biocompatibility with low cytotoxicity. These unique self-assembled systems thus have many possible biomedical applications, such as a sustained delivery of high-dosed water insoluble drugs, quick effective drugs for trauma, controlled delivery of the oral-administration drugs, and so forth.     

Effect of network connectivity on the mechanical and transport properties of block copolymer gels

Establishing the independent tunability of transport and mechanical properties in polymer gels would significantly contribute to their implementation as transdermal drug delivery media, among other things. The work conducted herein uses facile changes in the formulation of physically crosslinked styrenic ABA/AB block copolymer organogels to alter their mechanical properties independently from the mass transport of an internally-loaded nanocarrier. Such independent tunability is made possible by altering the relative amounts of ABA triblock and AB diblock copolymers while holding total copolymer concentration fixed. Specifically, three series of gels each with a fixed total copolymer concentration (10, 20, or 30 wt%) comprised of varying triblock copolymer concentration are studied. Small angle x-ray scattering confirms that, at the nanoscale, only gel network connectivity changes within each series, while mechanical and release experiments show that increasing network connectivity leads to significant growth of gel moduli, but little change in nanocarrier release rate.     

Hybrid cross‐linked hydrogels as a technology platform for in vitro release of cephradine

Hydrogel‐based drug delivery systems can leverage therapeutically favorable upshots of drug release and found clinical uses. Hydrogels offer temporal and spatial control over the release of different therapeutic agents. Because of their tailor made controllable degradability, physical properties, and ability to prevent the labile drugs from degradation, hydrogels provide platform on which diverse physicochemical interactions with entrapped drugs cause to control drug release. Herein, we report the fabrication of novel vinyltrimethoxy silane (VTMS) cross‐linked chitosan/polyvinyl pyrrolidone hydrogels. Swelling in distilled water in conjunction with different buffer and electrolyte solutions was performed to assess the swellability of hydrogels. Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), and X‐ray diffraction (XRD) analysis were further conducted to investigate the possible interactions between components, thermal stability, and crystallinity of as‐prepared hybrid hydrogels, respectively. In vitro time‐dependent biodegradability, antimicrobial study, and cytotoxicity were also carried out to evaluate their extensive biocompatibility and cytotoxic behavior. More interestingly, in vitro drug release study allowed for the controlled release of cephradine. Therefore, this facile strategy developed the novel biocompatible and biodegradable hybrid hydrogels, which could significantly expand the scope of these hydrogels in other biomedical applications like scaffolds, skin regeneration, tissue engineering, etc.     

Effects of thermosensitivity of poly (N-isopropylacrylamide) hydrogel upon the duration of a lag phase at the beginning of drug release from the hydrogel

The release rates of three kinds of drugs, with different charges, from poly (N-isopropylacrylamide) hydrogels were studied. The release rate was observed to be temperature dependent for the types of drug. When the temperature was lower than the phase transition temperature, the release rate was higher at lower temperatures and increased as the temperature rose. The amount of drugs released from a poly (N-isopropylacrylamide) hydrogel disk was plotted against the square root of time. It was found that the amount of drugs released was proportional to the square root of time over a certain time interval. A lag phase was observed before the amount of drug released became proportional to the square root of time. The longest time lag was observed at the phase transition temperature of poly (N-isopropylacrylamide); LCST (33°C). This suggests that the penetration rate of water into the hydrogels is lowest at the phase transition temperature and drastically changes around it. The release rates of drugs was also affected by the charges of the drug molecules. This may be caused by the interaction of drug molecules with polymer chains. When anionic drugs are released, the electrostatic repulsion seems to act between polymer chains and drug molecules. Therefore, the lag phase observed at the beginning of the release of anionic drugs was shorter, as compared with other kinds of drugs at any temperatures between 25 and 40°C. On the other hand, when cationic drugs are released, the time lag was longer at temperatures higher than 33°C as compared with the time lag at lower temperatures. At temperatures higher than 33°C, drugs are released from the surface skin layer of the hydrogel where water molecules are less mobile than those in bulk distilled water. The drug release thus shows a long lag phase.     

魔芋葡甘聚糖/聚乙烯醇纳米纤维膜及其释药行为研究

为了研制药物缓释效果优良的薄膜材料,利用静电纺丝设备研制不同比重的魔芋葡甘露聚糖/聚乙烯醇纳米纤维膜,并通过扫描电镜、傅里叶变换红外光谱和示差扫描量热法表征纳米纤维膜的结构和性能,结合体外实验和数学模型研究其缓释行为.结果显示当魔芋葡甘露聚糖含量占纳米纤维膜总质量约76%时,纳米纤维膜中微纤丝粗细最均匀且结点较少,纳米纤维膜中魔芋葡甘聚糖和聚乙烯醇之间存在明显的相互作用,含有5-氨基水杨酸的纳米纤维膜在pH=7.4 PBS磷酸盐缓冲液中25 h的累积释放量大约为45%,显示出良好的药物缓释效果,其缓释行为与Higuchi模型具有较高的拟合度.研究表明利用静电纺丝设备研制的魔芋葡甘聚糖/聚乙烯醇纳米纤维膜可以为药物缓释载体的开发提供理论依据.     

A bioinspired 4D printed hydrogel capsule for smart controlled drug release

With the ever-increasing demands for personalized drugs, disease-specific and condition-dependent drug delivery systems, four-dimensional (4D) printing can be used as a new approach to develop drug capsules that display unique advantages of self-changing drug release behavior according to the actual physiological circumstances. Herein, a plant stomata-inspired smart hydrogel capsule was developed using an extrusion-based 4D printing method, which featured with UV cross-linked poly(N-isopropylacrylamide) (PNIPAM) hydrogel as the capsule shell. The lower critical solution temperature (LCST) of the PNIPAM hydrogels was approximately 34.9 °C and macroporous PNIPAM hydrogels were prepared with higher molecular weight polyethylene glycols (PEGs) as the pore-forming agents. Owing to the LCST-induced shrinking/swelling properties, the prepared PNIPAM hydrogel capsules exhibited temperature-responsive drug release along with the microstructure changes in the PNIPAM hydrogels. The in vitro drug release test confirmed that the PNIPAM hydrogel capsules can autonomously control their drug release behaviors on the basis of ambient temperature changes. Moreover, the increased PEG molecular weights in the macroporous PNIPAM hydrogel capsules caused an obvious improvement of drug release rate, distinctly indicating that the drug release profiles can be well programmed by adjusting the internal pore size of the hydrogel capsules. In vitro biocompatibility studies confirmed that the PNIPAM hydrogel capsules have great potential for biomedical applications. The bioinspired 4D printed hydrogel capsules pioneer the paradigm of smart controlled drug release.     

In vitro drug release from silicone rubber–polyacrylamide composite

Composite materials containing drugs were prepared from silicone rubber and hydrogel. Cross linked polyacrylamide (PAAm) hydrogel particles were incorporated into a silicone rubber to enhance the hydrophilicity and drug release capacity of silicone rubber as a matrix. Progesterone and Thymol Blue were used as a hydrophobic and hydrophilic drug model, respectively. Different amounts of polyacrylamide (PAAm) were mixed with the drugs and uncured silicone rubber at room temperature. The composite matrices were formed using a compression molding press and cured by thermal and γ-irradiation curing methods. In vitro drug release behavior of composites and their physical and mechanical properties were investigated. The results indicated that the hydrophilic character of silicone rubber was more pronounced with increasing the amount of PAAm. Also, a significant effect on the drug release profiles was observed. The γ-irradiation curing method improved mechanical properties of composites and affected the drug release profiles. It was found that the amounts of released progesterone from γ-irradiated samples increased in comparison with the thermally cross linked composite since released Thymol Blue was reduced.